0 CHECKOUT

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review

  • ID: 1314900
  • November 2015
  • 45 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Eli Lilly and Company
  • ICF International, Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Zaptronix Limited
  • MORE

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Eli Lilly and Company
  • ICF International, Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Zaptronix Limited
  • MORE

List of Tables

List of Figures

Section 1 - About the Company

Spherix Incorporated - Key Facts

Spherix Incorporated - Key Employees

Spherix Incorporated - Key Employee Biographies

Spherix Incorporated - History

Spherix Incorporated - Company Statement

Spherix Incorporated - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Spherix Incorporated - Business Description

Spherix Incorporated - Corporate Strategy

Spherix Incorporated - SWOT Analysis

SWOT Analysis - Overview

Spherix Incorporated - Strengths

Strength - Strong Intellectual Property

Strength - Unique Operational Portfolio

Spherix Incorporated - Weaknesses

Weakness - History of Losses

Weakness - Legal Proceedings

Spherix Incorporated - Opportunities

Opportunity - IP Monetization industry

Spherix Incorporated - Threats

Threat - Competitive Pressures

Threat - Regulatory Changes

Spherix Incorporated - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Spherix Incorporated, Recent Deals Summary

Section 4 – Company’s Recent Developments

Aug 14, 2015: Spherix Reports Q2 2015 Results

Jul 02, 2015: Spherix Issues A Litigation Update

May 11, 2015: United States Patent & Trademark Office Issues Another Standard-Essential Patent to Spherix

May 08, 2015: Spherix Reports Q1 2015 Results

Mar 30, 2015: Spherix Reports 2014 Results

Mar 30, 2015: Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon

Mar 13, 2015: Spherix Provides Update on Matters Against VTech and Uniden

Nov 13, 2014: Spherix Reports Q3 2014 Results

Oct 28, 2014: Spherix Completes Technology Tutorial To Court. Next Key Date November 21st

Oct 23, 2014: Spherix Provides Litigation Update

Section 5 – Appendix

Methodology

Ratio Definitions

About Us

Contact Us

Disclaimer

List of Tables

Spherix Incorporated, Key Facts

Spherix Incorporated, Key Employees

Spherix Incorporated, Key Employee Biographies

Spherix Incorporated, History

Spherix Incorporated, Subsidiaries

Spherix Incorporated, Key Competitors

Spherix Incorporated, Ratios based on current share price

Spherix Incorporated, Annual Ratios

Spherix Incorporated, Interim Ratios

Spherix Incorporated, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Spherix Incorporated, Performance Chart (2010 - 2014)

Spherix Incorporated, Ratio Charts

Note: Product cover images may vary from those shown
3 of 4

Zaptronix Limited
Sanofi
Eli Lilly and Company
Novo Nordisk A/S
ICF International, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.